← Back
Data updated: Jun 28, 2026
PURITY CYLINDER GASES, INC
Pharma Pharmaceuticals
PURITY CYLINDER GASES, INC is a pharmaceutical company with 1 FDA-approved products.
2013
Since
1
Drugs
-
Trials
2
New Drugs (2yr)
Modality:
1 Small Molecules
PURITY CYLINDER GASES, INC's Key Drugs
PURITY CYLINDER GASES, INC's core commercial portfolio centers on MEDICAL AIR, USP — its most strategically important drugs approved in the last 15 years.
PURITY CYLINDER GASES, INC's Recent FDA Approvals
PURITY CYLINDER GASES, INC secured 2 new FDA approvals for novel drugs (NDA/BLA) in the last two years.
PURITY CYLINDER GASES, INC's Therapeutic Areas
Disease areas where PURITY CYLINDER GASES, INC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
PURITY CYLINDER GASES, INC Pipeline Snapshot
Active clinical trials for PURITY CYLINDER GASES, INC across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • MEDICAL AIR, USP leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2013-07-14
- Latest
- 2013-07-14
- Applications
- 1